• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Selskabsmeddelelse

Major shareholder announcement

BioMar Group

COMPANY ANNOUNCEMENT NO. 06-2026

1 June 2026

 

With reference to company announcements no. 01-2026 dated 19 May 2026, the offering circular as published by BioMar Group A/S (“BioMar”) in connection with the initial public offering (the “Offering”) and admission to trading and official listing of BioMar’s shares on Nasdaq Copenhagen A/S on 19 May 2026 (the “Offering Circular”), company announcements no. 02-2026 dated 28 May 2026 regarding the result of the Offering, and no. 05-2026 regarding completion of the Offering and registration of the capital increase, BioMar hereby announces that it has received the following notification pursuant to Section 38 of the Danish Capital Markets Act regarding Aktieselskabet Schouw & Co.’s (“Schouw & Co.”) holding of shares in BioMar.

Prior to completion of the Offering, Schouw & Co. held 100,000,000 shares in BioMar, corresponding to 100% of BioMar’s share capital and voting rights.

Schouw & Co. has reduced its shareholding in BioMar as a consequence of:

  1. the dilution resulting from BioMar’s issuance of 463,000 new shares of a nominal value of DKK 2.50 each in connection with the Offering;
  2. the sale of 24,700,000 shares in BioMar of a nominal value of DKK 2.50 each in connection with the Offering; and
  3. the lending of 3,774,450 shares in BioMar of a nominal value of DKK 2.50 each to the Joint Global Coordinators/DNB Carnegie Investment Bank, Filial af DNB Carnegie Investment Bank AB (PUBL), Sverige for the purposes of delivery of shares to investors as a result of the overallotment facility in connection with the Offering.

Following completion and settlement of the above transactions in connection with the Offering and assuming full exercise of the Overallotment Option, Schouw & Co. will hold a total of 71,525,550 shares (i.e. excluding lending shares pursuant to the overallotment facility, which may be redelivered solely to cover overallotments or short positions) of a nominal value of DKK 2.50 each, corresponding to 71.20% of the share capital and voting rights in BioMar.

Contact details:

Sif Rishoej, VP People, Purpose & Communication, BioMar Group A/S, +45 23 83 91 71

Magnhild Sæbø, Chief Legal Officer, BioMar Group A/S, +45 23 62 17 22

Information about BioMar

BioMar is a leading global aquafeed solutions provider, focusing on the attractive segment of high‑value species such as salmon, warm‑water shrimp, trout, sea bass and sea bream and many other high-value fish. BioMar operates 16 feed production facilities and five technology centres located in the major aquaculture hubs in Europe, Latin America and Asia. In total, BioMar supplies high-value feed for more than 45 different species, offering its products in more than 90 countries to approx. 1,400 customers.

Since BioMar became part of Schouw & Co. in 2005, consolidated revenue has grown by 10% per year on average, reaching a revenue of DKK 16.5 billion in 2025. Earnings (EBIT) have grown even faster, with an annual average growth rate of 12%, exceeding DKK 1.1 billion in 2025. BioMar’s full 2025 Annual Report and Q1 2026 interim report can be found at www.biomar.com.

Global demand for protein is rising due to an expanding global population, with aquaculture emerging as one of the fastest growing and most sustainable sources of non-plant proteins. This positions aquaculture as a key driver in bridging the gap between rising protein demand and constrained supply.

Over the years, it has become evident that feed is far more than an enabler of growth. It is also impacting the quality of seafood end-products, and with the right nutritional solutions, fish and shrimp can thrive, build greater resilience, and mitigate health challenges, all while lowering environmental impact through the use of circular and restorative raw materials. Feed is particularly important to the aquaculture value chain, generally accounting for up to 80% of farmers of high value species’ carbon footprint and more than 50% of their operating expenses.

BioMar’s position in the value chain, its diversification across species and geographies, as well as strong innovation and sustainability credentials allow it to stay at the forefront of the sector’s evolution from commoditised feed to sophisticated ingredient solutions, resulting in greater visibility on earnings and stronger resilience.


Attachments
CA 06-26 - Major shareholders.pdf